secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001493152-26-009478
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics regains Nasdaq compliance; preliminary cash $11.9M as of Dec 31, 2025
--------------------------------------------------------------------------------

- Nasdaq notified Co-Diagnostics (CODX) of compliance with $1.00 bid price rule; trading resumes March 11, 2026.
- Nasdaq Hearing Panel closed; one-year Discretionary Panel Monitor imposed through March 9, 2027.
- If bid price falls below $1.00 for 30 consecutive trading days, no 180-day cure period; delist determination possible.
- Preliminary cash and cash equivalents estimated at $11.9M as of December 31, 2025; unaudited and subject to adjustment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226009478/0001493152-26-009478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226009478/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-009478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer